290 related articles for article (PubMed ID: 27497264)
21. Expression of Salivary S100A7 Levels in Stage I Oral Submucous Fibrosis: A Clinical and Laboratory Study.
Raffat MA; Hadi NI; Alghamdi O; Al-Aali KA; Al Deeb M; Abduljabbar T; Vohra F
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1115-1119. PubMed ID: 32334479
[TBL] [Abstract][Full Text] [Related]
22. Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets.
Qin X; Ning Y; Zhou L; Zhu Y
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902423
[TBL] [Abstract][Full Text] [Related]
23. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.
Chiu CJ; Chang ML; Chiang CP; Hahn LJ; Hsieh LL; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):646-53. PubMed ID: 12101112
[TBL] [Abstract][Full Text] [Related]
24. Estimation of copper in saliva and areca nut products and its correlation with histological grades of oral submucous fibrosis.
Mohammed F; Manohar V; Jose M; Thapasum AF; Mohamed S; Shamaz BH; D'Souza N
J Oral Pathol Med; 2015 Mar; 44(3):208-13. PubMed ID: 25047540
[TBL] [Abstract][Full Text] [Related]
25. Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.
Shen YW; Shih YH; Fuh LJ; Shieh TM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008091
[TBL] [Abstract][Full Text] [Related]
26. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
27. Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Indian J Dent Res; 2022; 33(3):272-276. PubMed ID: 36656187
[TBL] [Abstract][Full Text] [Related]
28. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
29. Oral submucous fibrosis: A clinicopathological study of 674 cases in China.
Cai X; Yao Z; Liu G; Cui L; Li H; Huang J
J Oral Pathol Med; 2019 Apr; 48(4):321-325. PubMed ID: 30715767
[TBL] [Abstract][Full Text] [Related]
30. Areca nut in pathogenesis of oral submucous fibrosis: revisited.
Angadi PV; Rao SS
Oral Maxillofac Surg; 2011 Mar; 15(1):1-9. PubMed ID: 20376683
[TBL] [Abstract][Full Text] [Related]
31. Roles of CYP1A1 and CYP2E1 Gene Polymorphisms in Oral Submucous Fibrosis.
Yaming P; Urs AB; Saxena A; Zuberi M
Asian Pac J Cancer Prev; 2016; 17(7):3335-40. PubMed ID: 27509973
[TBL] [Abstract][Full Text] [Related]
32. High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster.
Mohiuddin S; Fatima N; Hosein S; Fatima N
J Pak Med Assoc; 2016 Nov; 66(11):1362-1366. PubMed ID: 27812049
[TBL] [Abstract][Full Text] [Related]
33. Raised tissue copper levels in oral submucous fibrosis.
Trivedy CR; Warnakulasuriya KA; Peters TJ; Senkus R; Hazarey VK; Johnson NW
J Oral Pathol Med; 2000 Jul; 29(6):241-8. PubMed ID: 10890553
[TBL] [Abstract][Full Text] [Related]
34. Oral submucous fibrosis: a clinico-histopathological study in Chennai.
Kiran Kumar K; Saraswathi TR; Ranganathan K; Uma Devi M; Elizabeth J
Indian J Dent Res; 2007; 18(3):106-11. PubMed ID: 17687172
[TBL] [Abstract][Full Text] [Related]
35. Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis.
Pant I; Rao SG; Kondaiah P
Sci Rep; 2016 Oct; 6():34314. PubMed ID: 27708346
[TBL] [Abstract][Full Text] [Related]
36. Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis.
Zhou S; Qu X; Yu Z; Zhong L; Ruan M; Ma C; Wang M; Zhang C; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):575-81. PubMed ID: 20303055
[TBL] [Abstract][Full Text] [Related]
37. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
38. Ki67, CD105 and α-smooth muscle actin expression in disease progression model of oral submucous fibrosis.
Gadbail AR; Chaudhary MS; Sarode SC; Gondivkar SM; Belekar L; Mankar-Gadbail MP; Dande R; Tekade SA; Yuwanati MB; Patil S
J Investig Clin Dent; 2019 Nov; 10(4):e12443. PubMed ID: 31325233
[TBL] [Abstract][Full Text] [Related]
39. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
40. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
